{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:30:23Z","timestamp":1790173823599,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s12032-007-0029-5","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T13:45:54Z","timestamp":1180532754000},"page":"413-418","source":"Crossref","is-referenced-by-count":6,"title":["Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma"],"prefix":"10.1007","volume":"24","author":[{"given":"M.","family":"Todorovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Balint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kraguljac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mihaljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Elezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Boskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Colovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, et al. A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361\u201392.","journal-title":"Blood"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V78.2.259.bloodjournal782259","volume":"78","author":"M Raffeld","year":"1991","unstructured":"Raffeld M, Jaffe ES. Bcl\u20131, t\u00a0(11; 14), and mantle cell\u2013derived lymphomas. Blood 1991;78:259\u201363.","journal-title":"Blood"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/32.2.6198355","volume":"32","author":"JL Cordell","year":"1984","unstructured":"Cordell JL, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti\u2013alkaline phosphatese (APAAP\u2013complexes). J Histoch Cytochem 1984;32:219\u201329.","journal-title":"J Histoch Cytochem"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/1042819021000035653","volume":"44","author":"CH Wohlschlaeger","year":"2003","unstructured":"Wohlschlaeger CH, Lange HM, Feller AC. Aberrant immunophenotypes of mantle cell lymphomas. Leuk Lymphoma 2003;44:269\u201373.","journal-title":"Leuk Lymphoma"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1080\/10428190410001723331","volume":"45","author":"E Matutes","year":"2004","unstructured":"Matutes E, et al. The leukemic presentation of mantle\u2013cell lymphoma: disease features and prognostic factors in 58 patients. Leuk Lymphoma 2004;45:2007\u201315.","journal-title":"Leuk Lymphoma"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","volume":"87","author":"DD Weisenburger","year":"1996","unstructured":"Weisenburger DD, Armitage JO. Mantle cell lymphoma; an entity comes of age. Blood 1996;87:4483\u201394.","journal-title":"Blood"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000046603","volume":"106","author":"Donfrid","year":"2001","unstructured":"Donfrid\u2013Todorovic M, et al. Monocytoid B cell lymphoma associated with antibodies to myelin\u2013associated glycoprotein and sulphated glucuronyl paragloboside. Acta Haematol 2001;106:130\u20132.","journal-title":"Acta Haematol"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergencyto.2006.06.018","volume":"171","author":"SJ Rodig","year":"2006","unstructured":"Rodig SJ, et al. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B\u2013cell lymphoproliferative disorders. Cancer Genet Cytogenet 2006;171:44\u201351.","journal-title":"Cancer Genet Cytogenet"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10428199609067588","volume":"21","author":"S Pittaluga","year":"1996","unstructured":"Pittaluga S, et al. Prognostic significance of bone marrow trephine biopsy and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 1996;21:115\u201325.","journal-title":"Leuk Lymphoma"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","volume":"12","author":"H Samaha","year":"1998","unstructured":"Samaha H, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998;12:1281\u20137.","journal-title":"Leukemia"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","volume":"82","author":"F Bosch","year":"1998","unstructured":"Bosch F, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;82:567\u201375.","journal-title":"Cancer"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2141.1998.00684.x","volume":"101","author":"PL Cohen","year":"1998","unstructured":"Cohen PL, Kurtin PJ, Donovan KA, Hanson CA. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Br J Haematol 1998;101:302\u201310.","journal-title":"Br J Haematol"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1440-1827.2006.01986.x","volume":"56","author":"SS Chuang","year":"2006","unstructured":"Chuang SS, et al. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1\u2013negative tumor expressing cyclin D2. Pathol Int 2006;56:440\u20138.","journal-title":"Pathol Int"},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cancergencyto.2006.04.002","volume":"169","author":"L Zhang","year":"2006","unstructured":"Zhang L, Kern WF, Yu Z, Mulvihill JJ. Li. Cryptic and complex chromosomal rearrangements and the deletion of TP53. Cancer Genet Cytogenet 2006;169:169\u201373.","journal-title":"Cancer Genet Cytogenet"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800716","volume":"20","author":"CC Yin","year":"2007","unstructured":"Yin CC, et al. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol 2007;20:1\u20137.","journal-title":"Mod Pathol"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2559.2005.02323.x","volume":"48","author":"M Parrens","year":"2006","unstructured":"Parrens M, et al. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features. Histopathology 2006;48:353\u201362.","journal-title":"Histopathology"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02919132","volume":"11","author":"M Sarfati","year":"1992","unstructured":"Sarfati M, Fournier S, Wu CY, Delespesse G. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res 1992;11:260\u201372.","journal-title":"Immunol Res"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/eji.1830200610","volume":"20","author":"JC Prinz","year":"1990","unstructured":"Prinz JC, Baur X, Mazur G, Rieber EP. Allergen\u2013directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon\u2013gamma. Eur J Immuno 1990;20:1259\u201364.","journal-title":"Eur J Immuno"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/eji.1830270232","volume":"27","author":"R Reljic","year":"1997","unstructured":"Reljic R, Cosentino G, Gould HJ. Function of CD23 in the response of human B cells to antigen. Eur J Immunol 1997;27:572\u20135.","journal-title":"Eur J Immunol"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/modpathol.3800677","volume":"19","author":"R Lai","year":"2006","unstructured":"Lai R, et al. Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated. Mod Pathol 2006;19:1498\u201305.","journal-title":"Mod Pathol"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000208899.15859.cb","volume":"30","author":"A Salar","year":"2006","unstructured":"Salar A, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol 2006;30:1274\u201380.","journal-title":"Am J Surg Pathol"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/cncr.22093","volume":"107","author":"C Nickenig","year":"2006","unstructured":"Nickenig C, et al. German Low\u2013Grade Lymphoma Study Group. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low\u2013Grade Lymphoma Study Group. Cancer 2006;107:1014\u201322.","journal-title":"Cancer"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00277-006-0193-2","volume":"86","author":"DS Ritchie","year":"2007","unstructured":"Ritchie DS, et al. The hyper\u2013CVAD\u2013rituximab chemotherapy programme followed by high\u2013dose busulfan, melphalan and autologous stem cell transplantation produces excellent event\u2013free survival in patients with previously untreated mantle cell lymphoma. Ann Hematol 2007;86:101\u20135.","journal-title":"Ann Hematol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0029-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-007-0029-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0029-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T13:41:32Z","timestamp":1587562892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-007-0029-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,31]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-0029-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,31]]}}}